Oct 31, 2024
1:1000
For every 1000 shares held, investors received 1. The price per share adjusted from $0.01 to $12.00.
The split itself did not change the total investment value.
Prostatype Genomics AB (STO:PROGEN) operates in the Medical specialties industry.
Prostatype Genomics AB company overviewProstatype Genomics AB's most recent stock split was on October 31, 2024. It was a 1-for-1000 reverse split, so shareholders received 1 share for every 1000 they held.
Prostatype Genomics AB (STO:PROGEN) has split its stock 5 times: a 523-for-500 split on June 29, 2022, a 2770-for-921 split on April 24, 2023, a 1549-for-1000 split on December 8, 2023, a 66-for-31 split on August 14, 2024, and a 1-for-1000 reverse split on October 31, 2024.
Prostatype Genomics AB has split its stock 5 times. This history records 5 splits between June 29, 2022 and October 31, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Prostatype Genomics AB's 1-for-1000 reverse split on October 31, 2024, every 1000 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Prostatype Genomics AB has not announced a new split in our records. Its most recent split was on October 31, 2024, 1 year ago. Companies announce splits in advance, and any new STO:PROGEN split will appear on this page.
Already premium?